Patrick Boerlin
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 54
- Endocrinology top 0.05%
- Escherichia coli research studies 31
- Infectious Diseases top 0.2%
- Clostridium difficile and Clostridium perfringens research 22
- Viral gastroenteritis research and epidemiology 17
- Parasitology top 0.5%
- Food Science top 0.1%
- Salmonella and Campylobacter epidemiology 43
-
- Pharmaceutical and Antibiotic Environmental Impacts 37
-
- Listeria monocytogenes in Food Safety 21
-
- Bacteriophages and microbial interactions 17
- Co-authors
- Richard J. Reid‐SmithCarlton GylesScott A. McEwenJ C PiffarettiPeter KuhnertFranziska Boerlin-PetzoldRoger P. JohnsonNicol Janecko
- Journals
- Applied and Environmental Microbiology (17 papers)Veterinary Microbiology (13 papers)Journal of Clinical Microbiology (12 papers)
- Partner nations
- CanadaSwitzerlandUnited States
In The Last Decade
Patrick Boerlin
154 papers receiving 8.5k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Molecular Medicine 2.6k
- Endocrinology 2.5k
- Infectious Diseases 3.1k
- Parasitology 1.0k
- Food Science 2.7k
Countries citing papers authored by Patrick Boerlin
This map shows the geographic impact of Patrick Boerlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Boerlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Boerlin more than expected).
Fields of papers citing papers by Patrick Boerlin
This network shows the impact of papers produced by Patrick Boerlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Boerlin. The network helps show where Patrick Boerlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick Boerlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 35 | |
| 5 | 2015 | 67 | |
| 6 | 2013 | 4 | |
| 7 | 2012 | 53 | |
| 8 | 2012 | 135 | |
| 9 | 2012 | 89 | |
| 10 | Special Issue — Antimicrobial Resistance | 2008 | 4 |
| 11 | 2007 | 14 | |
| 12 | 2006 | 43 | |
| 13 | 2006 | 34 | |
| 14 | 2006 | 29 | |
| 15 | 2006 | 37 | |
| 16 | 2003 | 6 | |
| 17 | Comparison of the value of DNA-fingerprinting techniques for the identification and taxonomical classification of Listeria species | 1998 | 4 |
| 18 | 1996 | 9 | |
| 19 | 1996 | 14 | |
| 20 | 1995 | 55 |
About Patrick Boerlin
Patrick Boerlin is a scholar working on Molecular Medicine, Endocrinology and Pollution, having authored 154 papers that have together received 9.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (54 papers), Salmonella and Campylobacter epidemiology (43 papers), Pharmaceutical and Antibiotic Environmental Impacts (37 papers), Escherichia coli research studies (31 papers), Clostridium difficile and Clostridium perfringens research (22 papers), Listeria monocytogenes in Food Safety (21 papers), Viral gastroenteritis research and epidemiology (17 papers) and Bacteriophages and microbial interactions (17 papers). The work is most often cited by research in Molecular Medicine (2.6k citations), Endocrinology (2.5k citations) and Infectious Diseases (3.1k citations). Patrick Boerlin has collaborated with scholars based in Canada, Switzerland and United States. Frequent co-authors include Richard J. Reid‐Smith, Carlton Gyles, Scott A. McEwen, J C Piffaretti, Peter Kuhnert, Franziska Boerlin-Petzold, Roger P. Johnson, Nicol Janecko, Vincent Perreten and G. Baranton. Their work appears in journals such as Applied and Environmental Microbiology, Veterinary Microbiology, Journal of Clinical Microbiology, PLoS ONE and Microbial Drug Resistance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.